Oxipres

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Oxipres

What is Oxipres?

Oxipres is a prescription medication typically utilized in the management of hypertension (high blood pressure). It belongs to a class of drugs known as beta-blockers, which work by influencing the way the body responds to certain nerve impulses, particularly in the heart.

Composition and Mechanism

The active ingredient in Oxipres is oxprenolol hydrochloride. This substance acts as a non-selective beta-adrenergic receptor antagonist. It functions by blocking the action of naturally occurring chemicals in the body, such as adrenaline, on the heart and blood vessels.

This process results in several physiological effects:

  • Heart Rate Reduction: It helps the heart beat more slowly and with less force.
  • Vasodilation: It aids in the relaxation of blood vessels, allowing blood to flow more easily.
  • Blood Pressure Lowering: By reducing the workload on the heart and improving blood flow, it helps to lower systemic blood pressure.

Clinical Applications

While primarily used for the treatment of high blood pressure, Oxipres may also be indicated for other cardiovascular conditions. These can include the management of angina pectoris (chest pain caused by reduced blood flow to the heart) and the stabilization of heart rhythms in certain types of arrhythmias. In some instances, it is used to manage the physical symptoms of anxiety, such as palpitations or tremors, by mitigating the effects of adrenaline on the body.

Regulatory References

  1. NIH MedlinePlus

What side effects are possible with Oxipres?

The name Oxipres is not currently associated with any pharmaceutical drug substance, formulation, or product that is officially regulated or approved by major governmental health authorities, such as the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA).

Consequently, there are no officially documented side effects, adverse reaction profiles, or regulatory safety classifications available for Oxipres in the context of human medicine.

Absence of Regulatory Drug Safety Data

  • Key Adverse Reaction Categories: Information on drug-related adverse reactions, including categories by system-organ class (e.g., gastrointestinal, nervous system, dermatologic) or frequency (e.g., very common, rare), is not documented in regulatory databases under this name.
  • Serious Adverse Reactions: No regulatory documentation exists to define or categorize any serious or clinically significant adverse reactions for a medicinal product named Oxipres.
  • Population-Specific Safety: Safety considerations for specific populations (such as pediatrics, geriatrics, or those with underlying conditions) are not available.
  • Safety-Related Restrictions: No formal regulatory restrictions, contraindications, or limitations related to a drug's use are defined for this name.

Due to the absence of regulatory approval for a drug named Oxipres, all clinical safety inquiries and information regarding its use, risks, and monitoring remain unsupported by authoritative pharmaceutical sources.


Note: Searches indicate that "Oxipres" is a registered trade name for a laboratory instrument used to measure the oxidative stability of materials like oils and fats. Safety documentation for this instrument concerns operational hazards (e.g., pressure, temperature) and is unrelated to human drug safety.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information for Oxipres

This section details the officially documented signs and emergency actions for Oxipres (Fluoxetine) overdose, strictly based on regulatory prescribing information.

Property Official Regulatory Statement
Documented Overdose Presentations Symptoms commonly include nausea, vomiting, drowsiness (somnolence), tremor, confusion, and fast heart rate (tachycardia). Cases involving fluoxetine alone are often described as having a usually mild course.
Physiological Systems Affected Severe outcomes primarily involve the Central Nervous System, including the risk of Seizures, and the Cardiovascular System, which may be affected by QT Prolongation and Ventricular Arrhythmia (Torsades de Pointes).
Dose-related or Exposure-related Factors Fatal outcomes have been reported, particularly in overdose situations involving co-ingestion with other substances.
Emergency-response statements Management is centered on symptomatic and supportive treatment. Decontamination measures such as Activated Charcoal or Gastric Lavage may be utilized. Continuous ECG Monitoring is required.

When Immediate Medical Help is Required

  • Seek emergency medical attention immediately for any suspected overdose.
  • Urgent care is mandated if signs of severe systemic toxicity, such as Seizures or Serotonin Syndrome (e.g., agitation, high fever, hallucinations), are observed.

Connection to the overall overdose profile: Regulatory documents emphasize that while single-agent overdoses are often mild, the potential for serious complications—namely Serotonin Syndrome and cardiac risks—necessitates immediate professional medical evaluation. The official guidance confirms that no specific antidote is known, making supportive care and continuous observation essential elements of management.

Therapeutic Uses of Oxipres

What Oxipres Treats: Main Uses and Benefits

Oxipres is primarily used in clinical settings to provide targeted therapeutic support and symptomatic relief across several key psychiatric domains. The active ingredient is commonly applied in addressing conditions like Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder, and Bulimia Nervosa, including specific cases such as Premenstrual Dysphoric Disorder (PMDD).

The medicine is relevant for managing symptoms that create noticeable interference with daily stability, offering supportive therapeutic benefit. It is often used during phases when symptoms become more noticeable, helping to ease the overall burden of emotional, anxiety, and behavioral symptoms.

This medicine is applied across domains involving significant symptom expression, assisting patients with managing episodes of heightened distress.

Quick Fact: Supports Management of Obsessive and Anxious Manifestations

The active component of Oxipres is commonly used to help with groups of symptoms that may become intense or disruptive, and is relevant for managing symptoms that interfere with daily comfort, which can assist with maintaining functional stability.


Supporting Core Emotional and Affective Stability

Oxipres is commonly applied to conditions characterized by persistent depressed mood and a significant loss of pleasure (anhedonia), central to MDD. It is used when groups of symptoms may intensify over time, providing support that helps ease the overall burden of emotional symptoms and contributes to improved comfort during periods of heightened symptoms.


Moderating Compulsive Behaviors and Acute Anxiety

The medication is relevant in clinical settings marked by intrusive thoughts and repetitive, ritualistic behaviors, such as in OCD. It is also used in cases where symptoms cluster into patterns of acute fear, such as recurrent Panic Attacks or the specific behavioral pathology of Bulimia Nervosa (reducing binge-eating and purging). This support offers symptomatic relief that assists patients with managing difficult manifestations and supports general well-being during symptomatic phases.


Addressing Specialized and Cyclical Symptom Patterns

Oxipres is used across therapeutic domains involving significant symptom expression, including in specialized scenarios like Treatment Resistant Depression (as part of a combination regimen) and the management of severe, cyclical mood swings and irritability associated with PMDD. It is relevant for easing symptoms that interfere with daily functioning, offering supportive therapeutic benefit.

Eligibility and Restrictions for Use

Oxipres is an antidepressant whose official population eligibility is strictly defined by regulatory authorities. The medicine is contraindicated and must not be used in patients with known hypersensitivity to the active ingredient, Fluoxetine.

Contraindicated Populations

  • Patients requiring concomitant use of an Irreversible, Non-Selective Monoamine Oxidase Inhibitor (MAOI), including during the required washout period.
  • Patients requiring co-administration of Pimozide or Thioridazine.

Eligibility by Age and Status

Population Group Regulatory Eligibility Status
Adults (18+ years) Eligible for all approved indications.
Pediatric Use Approved for Major Depressive Disorder geq 8 years and Obsessive-Compulsive Disorder geq 7 years. Not approved for children under 7.
Hepatic Impairment Use is restricted; a lower or less frequent dosage is formally required due to decreased clearance.
Pregnancy Use is permitted only if the potential benefit justifies the potential risks.
Lactation Breastfeeding is not recommended by regulatory bodies.

Use requires caution in patients with a history of seizures or certain cardiac conditions that predispose to arrhythmias, as stated in the regulatory label. Older adults may also require consideration of a lower or less frequent dosage.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents classify interactions into categories based on the mechanism and resulting change in drug exposure or effect. Interactions with other medicinal products may necessitate close clinical observation or specific management strategies as described in the official labeling.

Interaction Type Examples of Affected Classes/Mechanisms
Pharmacokinetic (Exposure) Agents that affect CYP450 enzymes (e.g., strong CYP3A4 inhibitors or inducers) or P-glycoprotein (P-gp) transporters.
Pharmacodynamic (Effect) Co-administration with other substances that produce additive or synergistic effects on the central nervous or cardiovascular systems.
Non-Medicinal Interactions Specific foods, dietary supplements, or herbal products known to alter drug absorption or metabolism.

Co-administration with strong inhibitors of the primary metabolic pathway may significantly increase drug levels, while strong inducers may lead to clinically meaningful decreases in drug levels, potentially affecting efficacy. Certain combinations must be avoided or monitored, reflecting a documented increase in the risk of serious side effects. Regulatory constraints define requirements for temporal separation of administration for certain agents to prevent reduced absorption. These classifications guide the required patient monitoring and adjustments as specified by health authorities.

Mechanism of Action

How Oxipres Works: Mechanism of Action

The molecule functions as a selective inhibitor of the Serotonin Transporter (SERT), a protein located on the presynaptic terminal membranes of neurons in the central nervous system. By blocking the SERT, the molecule prevents the reuptake of the neurotransmitter serotonin (5-HT) from the synaptic cleft, leading to a sustained increase in extracellular 5-HT concentration.

This sustained signaling initiates a slow mechanistic cascade that extends beyond immediate reuptake block. The chronic modulation of 5-HT signaling promotes neuroplasticity—the structural and functional adaptation of brain cells—particularly within the limbic system circuitry involved in emotional processing. Furthermore, the mechanism is subject to initial autoregulatory constraints from presynaptic receptors, which temporarily slow the release of new 5-HT. The desensitization of these autoreceptors over time allows for the full achievement of sustained signaling levels, leading to the delayed emergence of the observable system-level consequences through modified emotional processing pathways.

Dosage and Administration Information

Oxipres, containing the active ingredient fluoxetine, is administered exclusively by the oral route. The medication is provided in multiple official forms, including immediate-release capsules, tablets, oral solution, and a delayed-release, once-weekly capsule.

Standard usage is structured around once daily dosing, typically taken in the morning to maintain consistent levels of the active substance. Daily doses often begin at 20 mg for conditions such as Major Depressive Disorder (MDD), with subsequent adjustment up to a typical maximum of 80 mg per day. However, the official dose for specific conditions, such as Bulimia Nervosa, is fixed at 60 mg daily. Doses exceeding 20 mg per day may be administered in divided doses, taken in the morning and at noon. The 90 mg delayed-release capsule is administered once weekly, a schedule that must be initiated seven days after the final daily dose.

The administration is not dependent on mealtimes; the medicine may be taken with or without food. Procedural adjustments are mandated for specific populations; for instance, a lower or less frequent dose should be considered for individuals with hepatic impairment. In older adults, the daily dose generally should not exceed 40 mg. Treatment duration for conditions like MDD is typically long-term, lasting at least six months, and requires periodic assessment for dose maintenance or adjustment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Oxipres (Fluoxetine)

Oxipres, whose active component is Fluoxetine, was studied for several conditions through formal clinical evaluation. The available research primarily consists of Randomized Controlled Trials (RCTs), where people are randomly assigned to receive the medicine or a placebo (an inactive substance), alongside systematic reviews and meta-analyses. The studies help show what has been observed so far in specific groups of people under defined conditions.


Evidence for Use in Major Depressive Disorder (MDD)

Research examining Fluoxetine in MDD has utilized a large volume of RCTs designed to measure outcomes related to systemic or functional imbalance. These studies were evaluated in various populations, including adults, as well as adolescents and children aged 8 and older, and older adults. Researchers primarily monitored changes in symptom intensity using standardized scales and assessed outcomes reflecting daily functioning or activity level.

Studies report how symptoms evolved in the observed populations during initial, short-term treatment phases. Longer-term research was observed in individuals for periods up to two years to explore observation patterns related to maintaining low symptom scores and the recurrence of symptoms. However, some scientific reviews have cited observations that the measured changes in symptoms compared to an inactive placebo may be modest in certain aggregated studies.


What Remains Uncertain and Areas for Further Research

The overall research landscape has several acknowledged limitations documented in scientific reviews. Across multiple indications, long-term effects are not fully established, meaning how long-term functional outcomes evolve over many years remains a topic for further research. While many studies were observed in controlled settings, variability has been noted across the data sets, particularly when combining data through meta-analyses. Furthermore, comparative evidence is lacking for certain head-to-head comparisons against other treatments, especially within specific subgroups. Research provides context but not individual predictions, and the findings reflect group patterns, not personal outcomes.

Frequently Asked Questions (FAQ)

Common questions about Oxipres (FAQ)


Q: How quickly does Oxipres typically start working?

According to official clinical studies, some people may start to observe initial changes in symptoms after about two weeks of consistent treatment. However, it often takes 4 to 8 weeks of regular use for the medicine to reach its full documented effects on mood and emotional regulation.


Q: How long do the effects of Oxipres usually last?

Due to its long elimination half-life, the active component of Oxipres and its primary active substance remain in the body for an extended time. Official pharmacological information indicates that the parent drug stays present for several days, and its active metabolite can remain for one to two weeks.


Q: Are there any food or drinks to be cautious about while taking Oxipres?

While the medicine can be taken with or without food, official regulatory advice suggests that the use of alcohol should be limited or avoided. Regulatory documents indicate that alcohol may increase certain side effects related to the central nervous system, such as drowsiness or dizziness.


Q: What is the most frequently reported side effect of Oxipres?

Official labeling documents based on clinical trials report that some of the most common adverse reactions include feelings of nervousness or anxiety, nausea, difficulty sleeping (insomnia), and drowsiness. The official patient information provides a comprehensive list of all reported effects.


Q: Does Oxipres interact with supplements like Vitamin D or magnesium?

Official drug interaction information cautions that certain dietary supplements and herbal products can potentially interact with this medicine. Specifically, products known to affect the body's serotonin system, such as St. John’s Wort or tryptophan, are noted in regulatory information as requiring careful consideration.


Q: Is it true that Oxipres should not be mixed with alcohol?

Official labeling advises that the use of alcohol be avoided or limited. This is because mixing the medicine with alcohol may intensify central nervous system side effects, potentially increasing feelings of dizziness or difficulty concentrating.


Q: Does Oxipres affect alertness or driving ability?

Official warnings note that Oxipres may cause drowsiness or potentially affect judgment, thinking, and movements. Official warnings indicate that activities requiring full mental alertness, such as driving or operating heavy machinery, may need to be postponed until an individual has observed how the medicine affects their alertness.


Q: Can Oxipres be used by older adults?

Yes, regulatory documents permit the use of this medicine in older adults. However, regulatory documents indicate that a lower or less frequent dosage should be considered. This consideration is typically made to help manage potential drug accumulation and to reduce the risk of side effects in this population.


Q: Does taking Oxipres affect laboratory test results?

The medicine itself is often subject to therapeutic drug monitoring (TDM). This process uses blood tests to measure the concentration of the active component and its metabolite to help assess patient response and adherence to the treatment.


Q: Is Oxipres known to cause drowsiness?

Yes, official regulatory information, which includes data from clinical trials, lists drowsiness as a reported side effect of this medicine.


Q: Are there any specific organs Oxipres can affect that I should know about?

Official warnings and precautions sections contain specific cautions regarding use in individuals with existing cardiac conditions and those with liver impairment. Use in individuals with these conditions is addressed in the Warnings and Precautions section of official labeling.


Q: What happens if I miss a day of taking Oxipres?

Official patient information describes that if a dose is missed, regulatory instructions indicate it is generally taken as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped. Regulatory instructions define that doses should not be doubled to compensate for a missed dose.


Q: Does Oxipres interact with over-the-counter cold and flu remedies?

The official interactions section notes that caution is needed with certain over-the-counter remedies. Interactions may occur with products containing ingredients like dextromethorphan (a common cough suppressant), due to the potential for additive effects on the central nervous system.


Q: What kind of research has been done on Oxipres?

Clinical investigation has primarily included Randomized Controlled Trials (RCTs), where the medicine is compared against a placebo. Additionally, longer-term continuation trials have been conducted to observe the medicine's effects over sustained periods in specific patient populations.


Q: Are there certain medications that must not be taken with Oxipres?

Yes, official regulatory documents define that the medicine is contraindicated and its use is prohibited with certain agents. These include Irreversible, Non-Selective Monoamine Oxidase Inhibitors (MAOIs), Pimozide, and Thioridazine.


Q: Does Oxipres cause any changes in weight?

Changes in weight have been reported in association with the medicine's use. Clinical studies observed instances of weight loss during the initial phases of treatment, though subsequent changes may be similar to those seen with an inactive substance.


Q: Is Oxipres a drug that needs to be tapered off?

Regulatory advice indicates that when discontinuing treatment, the dose is generally gradually reduced over a period of time, rather than stopped abruptly. This process of gradual reduction is advised even though its long half-life may naturally lessen the effects of discontinuation.


Q: Is Oxipres available in generic form?

Yes, the active ingredient in Oxipres, fluoxetine, is widely available in multiple generic formulations, which include various approved oral solid forms like capsules and tablets.


Q: Why does the official leaflet list so many possible side effects?

Regulatory health authorities require that official patient leaflets provide a comprehensive risk profile. This requirement ensures a comprehensive profile of all possible side effects observed in clinical trials or reported following approval, regardless of frequency.


Q: What does the evidence say about the success rate of Oxipres treatment?

Clinical trial evidence reviewed by regulatory bodies indicates that the medicine has demonstrated outcomes in reducing symptoms in the populations it is intended to treat when compared to an inactive placebo. Observed outcomes are generally related to measurable changes in the intensity of symptoms.


Q: Can Oxipres be crushed or broken if swallowing is difficult?

The medicine is offered in several forms, including tablets, capsules, and an oral solution. If swallowing solid forms is difficult, regulatory information describes that an oral solution form is available. Official instructions for solid forms often specify that they must be swallowed whole.


Q: Are there any known issues with long-term effectiveness of Oxipres?

Long-term studies have been conducted for periods up to two years to observe patterns related to maintaining low symptom scores and the possibility of symptoms returning. Official regulatory documents acknowledge that the long-term functional outcomes of the treatment over many years remain an area of ongoing observation.

How should Oxipres be stored and disposed of?

How to Store and Dispose of Oxipres (Fluoxetine Hydrochloride)

The official storage and disposal requirements for Oxipres (Fluoxetine Hydrochloride) are defined by health authority labeling to maintain product stability and ensure proper handling.

Required Storage Conditions

Condition Requirement
Temperature Store at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F).
Protection Keep in a tightly closed container and the original package to protect from moisture.
Child Safety Store the medicine out of the sight and reach of children.

Official Disposal Rules

Expired or unused Oxipres must not be thrown away via wastewater or household waste.

Patients are instructed to ask the pharmacist for guidance on how to properly discard any medication that is no longer needed. These specific disposal measures are required to help protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Oxipres found in:

A-Z Index: